ghk-cu injectable peptide side effects 5 GHK Cu Peptide Injection
Description
255 GLP-1(7-36) stimulates the release of paracrine glucagon inhibitory factors by activating GLP-1R on -cells and -cells

These products are not approved for human or veterinary use

Pinealon research suggests it mitigates cellular aging in the central nervous system

Archived from the original on August 17, 2016

They are not FDA-approved drugs
